212
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Medicalisation or under-treatment? Psychotropic medication use by elderly people in New Zealand

, , , , , , , & show all
Pages 202-218 | Received 02 Dec 2010, Accepted 04 Mar 2011, Published online: 17 Dec 2014

References

  • Ajwani, S.; Blakely, T.; Robson, B.; Tobias, M.; and Bonne, M. (2003) Decades of disparity: Ethnic mortality trends in New Zealand 1980-1999 Ministry of Health and University of Otago: Wellington.
  • Aparasu, R. R.; Mort, J. R.; and Brandt, H. (2003) ‘Psychotropic prescription use by community-dwelling elderly in the United States’ Journal of the American Geriatric Society 51:671–677.
  • Blakely, T.; Fawcett, J.; Atkinson, J.; Tobias, M.; and Cheung, J. (2005) Decades of disparity II: Socioeconomic mortality trends in New Zealand, 1981–1999 Ministry of Health: Wellington.
  • Braverman, P. (2006) ‘Health disparities and health equity: Concepts and measurement’ Annual Review of Public Health 27:167–194.
  • Cass, A.; Cunningham, J.; Snelling, P.; Wang, Z.; and Hoy, W. (2003) ‘Renal transplantation for Indigenous Australians: Identifying the barriers to equitable access’ Ethnicity and Health 8(2):111–119.
  • Cohen, C. (1993) ‘The biomedicalization of psychiatry: A critical overview’ Community Mental Health Journal 29(6):509–521.
  • Conrad, P. (2005) ‘The shifting engines of medicalization’ Journal of Health and Social Behaviour 46:3–14.
  • Conrad, P. (2007) The medicalization of society: On the transformation of human conditions into treatable disorders The Johns Hopkins University Press: Baltimore.
  • Conrad, P.; and Leiter, V (2004) ‘Medicalization, markets and consumers’ Journal of Health and Social Behaviour 45(extra issue):158–176.
  • Cooperstock, R. (1976) ‘Psychotropic drug use among women’ Canadian Medical Association Journal 115:760–763.
  • Crengle, S.; Lay-Yee, R.; Davis, P.; and Pearson, J. (2005) A comparison of Māori and non-Māori patient visits to doctors: The National Primary Medical Care Survey (NatMedCa): 2001/02 Report 6 Ministry of Health, Wellington, p. 140.
  • Dowell, A.; Garrett, S.; Collings, S.; McBain, L.; McKinlay, E.; and Stanley, J. (2009) Evaluation of the Primary Mental Health Initiatives: Summary report 2008 University of Otago and Ministry of Health: Wellington.
  • Dumit, J.; and Greenslit, N. (2006) ‘Informated health and ethical identity management’ Culture, Medicine and Psychiatry 30:127–134.
  • Eames, M.; Ben-Shlomo,Y.; and Marmot, M. G. (1993) ‘Social deprivation and premature mortality: Regional comparison across England’ British Medical Journal 307(6912):1097–1102.
  • Graham, K.; and Vidal-Zeballos, D. (1998) ‘Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): The relationship with gender, age and use of other substances’ Social Science and Medicine 46(3):381–395.
  • Herzberg, D. (2006) ‘“The pill you love can turn on you”: Feminism, tranquilizers, and the valium panic of the 1970s’ American Quarterly 58(1):79–103.
  • Horsburgh, S.; Norris, P.; Becket, G.; Crampton, P.; Arroll, B.; Cumming, J.; Herbison, P.; and Sides, G. (2010) ‘The equity in prescriptions medicines use study: Using community pharmacy databases to study medicines utilisation’ Journal of Biomedical Informatics 43(6):982–987.
  • Illich, I. (1976) Medical nemesis Pantheon: New York.
  • Isacson, D.; and Haglund, B. (1988) ‘Psychotropic drug use in a Swedish community: The importance of demographic and socioeconomic factors’ Social Science and Medicine 26(4):477–483.
  • Jatrana, S.; Crampton, P.; and Norris, P. (2010) ‘Ethnic differences in access to prescription medication because of cost in New Zealand’ Journal of Epidemiology and Community Health doi:10.1136/jech.2009.099101
  • Jha, A. K.; Varosy, P. D.; Kanaya, A. M.; Hunninghake, D. B.; Hlatky, M. A.; Waters, D. D.; Furberg, C. D.; and Shlipak, M. G. (2003) ‘Differences in medical care and disease outcomes among black and white women with heart disease’ Circulation 108(9):1089–1094.
  • Kaufert, P.; and Gilbert, P. (1986) ‘The context of menopause: Psychotropic drug use and menopausal status’ Social Science and Medicine 23(8):747–755.
  • King, A. (2001) The Primary Health Care Strategy Ministry of Health: Wellington.
  • Kivela, S.; Kongas-Saviaro, P.; Laippala, P.; Pahkala, K.; and Kesti, E. (1996) ‘Social and psychosocial factors predicting depression in old age: A longitudinal study’ International Psychogeriatrics 8(4):635–644.
  • Marmot, M. (2007) ‘Achieving health equity: From root causes to fair outcome’ The Lancet 370(9593):1153.
  • Martin, E. (2006) ‘The pharmaceutical person’ Biosocieties 1(3):273–287.
  • Martins, S.; Soares, M.; Foppe, J.; and Cabrita, J. (2006) ‘Inappropriate drug use by Portugese elderly outpatients – Effect of the Beers criteria update’ Phamacy World and Science 28:296–301.
  • Ministry of Health, New Zealand. (2009) Mortality and demographic data 2006 Ministry of Health: Wellington.
  • Mintzes, B. (2002) ‘Direct to consumer advertising is medicalizing normal human experience’ BMJ 324(7342):908–911.
  • Morgan, S. G.; Bassett, K. L.; Wright, J. M.; Evans, R. G.; Barer, M. L.; Caetano, P. A.; and Black, C. D. (2005) ‘“Breakthrough” drugs and growth in expenditure on prescription drugs in Canada’ British Medical Journal 331(7520):815–816.
  • Moynihan, R.; Heath, I.; and Henry, D. (2002) ‘Selling sickness: The Pharmaceutical industry and disease mongering’ British Medical Journal 324:886–891.
  • Moynihan, R.; and Henry, D. (2006) ‘The fight against disease mongering: Generating knowledge for action’ PLoS Medicine 3(4 e191):0425–0428.
  • Murray, J.; Williams, P.; and Clare, A. (1982) ‘Health and social characteristics of long-term psychotropic drug takers’ Social Science and Medicine 16(18):1595–1598.
  • Newman, L.; Mason, J.; Cote, D.; Vin, Y.; Carolin, K.; Bouwman, D.; and Colditz, G. (2002) ‘African-American ethnicity, socioeconomic status, and breast cancer survival: A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast’ Cancer 94(11):2844–2854.
  • Nolan, L.; and O’Mally, K. (1989) ‘The need for a more rational approach to drug prescribing for elderly people in nursing homes’ Age and Ageing 18:52–56.
  • Oakley-Browne, M.; Wells, J.; and Scott, K. (2006) Te Rau Hinengaro: The New Zealand mental health survey Ministry of Health: Wellington.
  • Okunade, A. A.; and Suraratdecha, C. (2006) ‘The pervasiveness of pharmaceutical expenditure inertia in the OECD countries’ Social Science and Medicine 63(1):225–238.
  • Peterson, E.; Shaw, L.; Delong, E.; Pryor, D.; Califf, R.; and Mark, D. (1997) ‘Racial variation in the use of coronary-revascularization procedures: Are the differences real? Do they matter?’ The New England Journal of Medicine 336:480–486.
  • PHARMAC. (2010) Annual Report for the year ended 30 June 2010 PHARMAC: Wellington.
  • Pharmaceutical Research and Manufacturers of America. (2003) Pharmaceutical Industry Profile 2003 Pharmaceutical Research and Manufacturers of America: Washington, DC.
  • Prince, M.; Harwood, R.; Blizard, R.; Thomas, A.; and Mann, A. (1997) ‘Social support deficits, loneliness and life events as risk factors for depression in old age. The Gospel Oak Project VI’ Psychological Medicine 27(02):323–332.
  • Rameka, R. (2006) He Arakanihi ki te Oranga: Report of health research council rangahau Hauora award Te Ropu Rangahau Hauora a Eru Pomare: University of Otago, Wellington.
  • Riska, E. (2003) ‘Gendering the medicalization thesis’ Gender Perspectives on Health and Medicine 7:59–87.
  • Robson, B.; and Harris, R. (2007) (eds.) Hauora: Māori Standards of Health IV.A study of the years 2000-2005. Te Ropu Rangahau Hauora a Eru Pomare, Wellington.
  • Robson, B.; Purdie, G.; and Cormack, D. (2006) Unequal impact: Maori and non-Māori cancer statistics 1996-2001 Ministry of Health: Wellington
  • Robson, B.; Purdie, G.; Cram, F.; and Simmonds, S. (2007) ‘Age standardisation - An indigenous standard?’ Emerging Themes in Epidemiology 4(1):3.
  • Rubin, L. (2004) ‘Merchandising madness, pills, promises, and better living through chemistry’ Journal of Popular Culture 38(2):369–383.
  • Russell, C. (1987) ‘Aging as a feminist issue’ Women’s Studies International Forum 10(2):125–132.
  • Salmond, C.; Crampton, P.; and Atkinson, J. (2007) NZDep2006 Index of Deprivation Department of Public Health, University of Otago: Wellington, p. 61.
  • Simoni-Wastila, L. (2000) ‘The use of abusable prescription drugs: The role of gender’ Journal of Women’s Health and Gender-Based Medicine 9:289–297.
  • Skegg, D.; Doll, R.; and Perry, J. (1977) ‘Use of medicines in general practice’ British Medical Journal (1):1561–1563.
  • Statistics New Zealand. (2006) QuickStats about Gisborne region Statistics New Zealand: Wellington.
  • Stein, J. (ed.). (1998) Internal medicine Mosby: St Louis.
  • Straand, J.; Sandvik, H.; and Rokstad, K. (1998) ‘General pracitioners’ office consultations with elderly patients – diagnoses and prescriptions: A report from the More and Romsdal Prescription Study’ Norwegian Journal of Epidemiology 8(2):121–126.
  • Tairawhiti District Health Board. (2010) Annual plan 2010–11 Tairawhiti District Health Board: Gisborne.
  • Thomas, D.; Arlidge, B.; Arroll, B.; and Elder, H. (2010) ‘General practitioners’ views about diagnosing and treating dpression in Māori and non-Māori patients’ Journal of Primary Health Care 2(3):208–216.
  • Tiefer, L. (2006) ‘Female sexual dysfunction: A case study of disease mongering and activist resistance’ PLoS Medicine 3(4):e178.
  • Tordoff, J.; Bagge, M.; Gray, A.; Campbell, A.; and Norris, P. (2010) ‘Medicines taking amongst community-dwelling people 75 years and older in an urban setting in New Zealand’ Age and Ageing 39(5):574–580.
  • Vuckovic, N.; and Nichter, M. (1997) ‘Changing patterns of pharmaceutical practice in the United States’ Social Science and Medicine 44(9):1285–1302.
  • Wagstaff, A. (2002) ‘Poverty and health sector inequalities’ Bulletin of World Health Organisation 80:97–105.
  • Weisz, G.; and Knaapen, L. (2009) ‘Diagnosing and treating premenstrual syndrome in five western nations’ Social Science and Medicine 68:1498–1505.
  • Wheeler, A.; Humberstone, V.; and Robinson, E. (2008) ‘Ethnic comparisons of antipsychotic use in schizophrenia’ Australian and New Zealand Journal of Psychiatry 42(10):863–873.
  • Wheeler, A.; Robinson, E.; and Robinson, G. (2005) ‘Admissions to acute psychiatric inpatient services in New Zealand: A demographic and diagnostic review’ New Zealand Medical Journal 118(1226):1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.